AMPICILLIN
Generic: AMPICILLIN SODIUM
Sandoz IncManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
AMPICILLIN SODIUMActive Substance
1971-03-03Original Approval
AMPICILLIN is FDA application ANDA061395, sponsored by SANDOZ. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Ampicillin for Injection, USP, 1 g per vial, 10-count box, Rx only, Distributed by: Auromedics Pharma, NDC 55150-113-10cGMP deviations: Temperature abuse
Class I2018-01-02
Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed bPresence of Particulate Matter: A confirmed customer report was received for the presence of visible
Class III2017-09-25
Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wrap packs (NLabeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pac
Class I2018-05-01
Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured Presence of Particulate Matter: confirmed customer report of the presence of visible particulate mat
Top Reported Reactions
1
DRUG INEFFECTIVE
962 reports
2
FOETAL EXPOSURE DURING PREGNANCY
674 reports
3
DRUG HYPERSENSITIVITY
624 reports
4
MATERNAL EXPOSURE DURING PREGNANCY
549 reports
5
PREMATURE BABY
524 reports
6
OFF LABEL USE
495 reports
7
PYREXIA
449 reports
8
ACUTE KIDNEY INJURY
360 reports
9
PREMATURE DELIVERY
345 reports
10
RENAL FAILURE
332 reports